Neuronetics (STIM) Cash from Financing Activities (2017 - 2026)

Neuronetics (STIM) has 10 years of Cash from Financing Activities data on file, last reported at -$5.6 million in Q1 2026.

• On a quarterly basis, Cash from Financing Activities fell 129.39% year-over-year to -$5.6 million in Q1 2026; TTM through Mar 2026 was $11.3 million, a 77.76% decrease from a year earlier, with the FY2025 full-year figure at $35.8 million, up 626.59% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$5.6 million, down from -$1.0 million in the prior quarter.
• Over the last five years, Cash from Financing Activities for STIM reached as high as $22.3 million in Q4 2023 and fell as low as -$5.6 million in Q1 2026.
• Historically, Cash from Financing Activities has averaged $5.2 million across 5 years, with a median of $127500.0 in 2022.
• On a YoY basis, Cash from Financing Activities climbed as much as 8985.71% in 2023 and fell as far as 720.0% in 2023.
• Year by year, Cash from Financing Activities stood at $245000.0 in 2022, then soared by 8985.71% to $22.3 million in 2023, then sank by 57.04% to $9.6 million in 2024, then tumbled by 110.76% to -$1.0 million in 2025, then tumbled by 441.98% to -$5.6 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were -$5.6 million in Q1 2026, -$1.0 million in Q4 2025, and $17.9 million in Q3 2025.